Latest Articles
Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer - OncLive
Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer OncLive
Published: April 8, 2024, 7 a.m.
Pennington Biomedical: Raising awareness of endometrial cancer - Greater Baton Rouge Business Report
Pennington Biomedical: Raising awareness of endometrial cancer Greater Baton Rouge Business Report
Published: April 8, 2024, 7 a.m.
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer - Li - 2024 - Advanced Science - Wiley Online Library
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer - Li - 2024 - Advanced Science Wiley Online Library
Published: April 6, 2024, 7 a.m.
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response - Nature.com
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response Nature.com
Published: April 2, 2024, 7 a.m.
Rate and risk factors of inadequate endometrial tissues after endometrial sampling among Bhutanese women at the national referral hospital of Bhutan: a cross-sectional study - BioMed Central
Rate and risk factors of inadequate endometrial tissues after endometrial sampling among Bhutanese women at the national referral hospital of Bhutan: a cross-sectional study BioMed Central
Published: April 2, 2024, 7 a.m.
Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer - OncLive
Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer OncLive
Published: April 2, 2024, 7 a.m.
Differential gene expression in decidualized human endometrial stromal cells induced by different stimuli - Nature.com
Differential gene expression in decidualized human endometrial stromal cells induced by different stimuli Nature.com
Published: April 2, 2024, 7 a.m.
Rubraca sheds positive light for PARP inhibitors in endometrial cancer - Clinical Trials Arena
Rubraca sheds positive light for PARP inhibitors in endometrial cancer Clinical Trials Arena
Published: April 2, 2024, 7 a.m.
LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination - Nature.com
LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination Nature.com
Published: April 2, 2024, 7 a.m.
Molecular Classification May Predict Survival Outcomes in Endometrial Cancer - Oncology Learning Network
Molecular Classification May Predict Survival Outcomes in Endometrial Cancer Oncology Learning Network
Published: April 1, 2024, 7 a.m.
Link copied to clipboard!